120 related articles for article (PubMed ID: 24532830)
1. Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trial.
Hamuryudan V; Hatemi G; Tascilar K; Yurdakul S; Mat C; Ozyazgan Y; Seyahi E; Ugurlu S; Yazici H
J Rheumatol; 2014 Apr; 41(4):735-8. PubMed ID: 24532830
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
Hamuryudan V; Hatemi G; Tascilar K; Sut N; Ozyazgan Y; Seyahi E; Mat C; Yurdakul S; Yazici H
Rheumatology (Oxford); 2010 Jan; 49(1):173-7. PubMed ID: 19995858
[TBL] [Abstract][Full Text] [Related]
3. [Behçet's disease].
Chiheb S; Chakib A; Lakhdar H
Ann Dermatol Venereol; 2003; 130(6-7):657-63. PubMed ID: 13679709
[No Abstract] [Full Text] [Related]
4. Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.
Chung MJ; Cheon JH; Kim SU; Park JJ; Kim TI; Kim NK; Kim WH
J Clin Gastroenterol; 2010 Jul; 44(6):e116-22. PubMed ID: 20054283
[TBL] [Abstract][Full Text] [Related]
5. Current therapy in Behcet's disease.
Sakane T; Takeno M
Skin Therapy Lett; 2000; 5(6):3-5. PubMed ID: 10889570
[TBL] [Abstract][Full Text] [Related]
6. Frequent oral ulceration during early disease may predict a severe disease course in males with Behçet's syndrome.
Hamuryudan V; Hatemi G; Sut N; Ugurlu S; Yurdakul S; Yazici H
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S32-4. PubMed ID: 22935508
[TBL] [Abstract][Full Text] [Related]
7. Tubulo-interstitial nephritis with Fanconi syndrome in Behçet disease.
Belmouaz S; Sechet A; Fernandez B; Ayache RA; Desport E; Bauwens M; Goujon JM; Gombert JM; Bridoux F; Touchard G
Nephrol Dial Transplant; 2007 Jul; 22(7):2079-83. PubMed ID: 17405783
[No Abstract] [Full Text] [Related]
8. [Ocular manifestation of Behçet disease (study of 50 patients consulting in dermatology department)].
Janati K; EL Omari K; Benchiki H; Hamdani M; Lakhdar H
Rev Med Interne; 2005 Oct; 26(10):771-6. PubMed ID: 16169129
[TBL] [Abstract][Full Text] [Related]
9. Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.
Davatchi F; Sadeghi Abdollahi B; Tehrani Banihashemi A; Shahram F; Nadji A; Shams H; Chams-Davatchi C
Mod Rheumatol; 2009; 19(5):542-9. PubMed ID: 19597921
[TBL] [Abstract][Full Text] [Related]
10. [Pseudotumorous presentation of neuro-Behçet: role of the withdrawal of colchicine?].
Vignes S; Vidailhet M; Dormont D; Soulié J; Wechsler B
Rev Med Interne; 1998 Jan; 19(1):55-9. PubMed ID: 9775117
[TBL] [Abstract][Full Text] [Related]
11. [Behçet's disease. Apropos of 32 cases].
Bitar E; Ghayad E; Ghoussoub K; Sinno W; Chams H; Khoury A; Baloglou P; Kallab K; Halaby C; Chemaly R
Rev Rhum Mal Osteoartic; 1986 Nov; 53(11):621-4. PubMed ID: 3616444
[TBL] [Abstract][Full Text] [Related]
12. Behçet syndrome: A great imitator.
Akdeniz N; Elmas ÖF; Karadağ AS
Clin Dermatol; 2019; 37(3):227-239. PubMed ID: 31178105
[TBL] [Abstract][Full Text] [Related]
13. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.
Masuda K; Nakajima A; Urayama A; Nakae K; Kogure M; Inaba G
Lancet; 1989 May; 1(8647):1093-6. PubMed ID: 2566048
[TBL] [Abstract][Full Text] [Related]
14. Behçet disease: clinical features and management in a Brazilian tertiary hospital.
Oliveira AC; Buosi AL; Dutra LA; de Souza AW
J Clin Rheumatol; 2011 Dec; 17(8):416-20. PubMed ID: 22089985
[TBL] [Abstract][Full Text] [Related]
15. [Behçet's disease].
Aouba A
Rev Prat; 2008 Mar; 58(5):533-40. PubMed ID: 18524110
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
[TBL] [Abstract][Full Text] [Related]
17. Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.
Yazici H; Barnes CG
Drugs; 1991 Nov; 42(5):796-804. PubMed ID: 1723375
[TBL] [Abstract][Full Text] [Related]
18. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.
Borstad GC; Bryant LR; Abel MP; Scroggie DA; Harris MD; Alloway JA
J Rheumatol; 2004 Dec; 31(12):2429-32. PubMed ID: 15570646
[TBL] [Abstract][Full Text] [Related]
19. [Effect of colchicine and streptokinase therapy on Budd-Chiari syndrome in Behçet's disease].
Varon D; Schattner A; Geltner D
Harefuah; 1983 Feb; 104(3):91-2. PubMed ID: 6618300
[No Abstract] [Full Text] [Related]
20. [Diagnosis and therapy for Behcet disease].
Hirohata S
Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2220-5. PubMed ID: 18044159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
